# Session Handoff
**Written:** 2026-04-18

## In Progress
- M20 — Stack-Wide Health & Version Compliance (branch: feature/stack-health-version-spec, commit d13f35b)
  - Implementation commit landed; hill chart still PLANNED — needs sync before PR
  - Success criteria unchecked; verify and check before marking DONE

## Completed This Session
- Roadmap sync: added M19 (DONE) and M20 (IN_PROGRESS) to PRD Section 6 (v0.12.0 → v0.13.0)
- M19 milestone file: Status → COMPLETE, all 5 hill-chart features → DONE (PR #23), all 6 success criteria checked
- `.add/config.json`: `planning.current_milestone` "M18" → "M20"

## Prior Session (2026-04-04)
- Spec: `specs/rxdag-ndc-migration.md` (16 ACs, 8 TCs)
- Plan: `docs/plans/rxdag-ndc-migration-plan.md` (18 tasks, 4 phases)
- Milestone: `docs/milestones/M19-rxdag-ndc-integration.md` created
- Cycle 14: all code changes implemented, tested, committed
- PR #23: `feature/rxdag-ndc-migration` merged to main (commit c72bdb3)

## Decisions Made
- `fda-ndc` transparently swapped to rx-dag (same slug, same consumer contract)
- Generic `headers` config field with `${ENV_VAR}` interpolation (not rx-dag-specific)
- `doRequest()` helper replaces `Client.Get()` at all 3 call sites in fetcher
- `fetchJSONPage` signature changed to accept full `Endpoint` (for header access)

## Blockers
- E2E tests need `RXDAG_API_KEY` env var set against live rx-dag at 192.168.1.145:8081
- **M13 remaining:** Production monitoring verification (1/6 criteria)
- **GA promotion:** 30-day stability window eligible today (2026-04-04)

## Next Steps
1. Review PR #23 (finish06/cash-drugs#23)
2. Set `RXDAG_API_KEY` env var and run E2E tests against live rx-dag
3. Merge to main
4. Deploy to staging
5. Verify production monitoring (M13 final criterion)
6. GA promotion retro
